Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
Arch closes $3B-plus fund to foster biopharma upstarts
On the heels of Bain's $3 billion fund, Arch Venture Partners has closed a VC fund of "more than $3 billion."
Fraiser Kansteiner
Sep 26, 2024 10:24am
Spanish VC closes $200M life sciences fund
Sep 26, 2024 5:00am
Fierce Biotech Fundraising Tracker: Genespire, Vicebio & more
Sep 25, 2024 10:20am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
Founder-led biotech raises $11M for preclinical cancer portfolio
Aug 20, 2024 11:05am
Halda's $126M will advance 'hold and kill' tumor drugs
Aug 12, 2024 7:00am